March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Exogenous PACAP Acts as a Retinoprotective Agent and a Modulator on Microglia/Macrophages Status in Mice NMDA-induced Retinal Injury Model
Author Affiliations & Notes
  • Yoshihiro Wada
    Department of Ophthalmology,
    Department of Anatomy,
    Showa University School of Medicine, Tokyo, Japan
  • Tomoya Nakamachi
    Department of Anatomy,
    Showa University School of Medicine, Tokyo, Japan
  • Kimi Endo
    Department of Ophthalmology,
    Department of Anatomy,
    Showa University School of Medicine, Tokyo, Japan
  • Tamotsu Seki
    Department of Ophthalmology,
    Department of Anatomy,
    Showa University School of Medicine, Tokyo, Japan
  • Seiji Shioda
    Department of Anatomy,
    Showa University School of Medicine, Tokyo, Japan
  • Ryohei Koide
    Department of Ophthalmology,
    Showa University School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships  Yoshihiro Wada, None; Tomoya Nakamachi, None; Kimi Endo, None; Tamotsu Seki, None; Seiji Shioda, None; Ryohei Koide, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6570. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yoshihiro Wada, Tomoya Nakamachi, Kimi Endo, Tamotsu Seki, Seiji Shioda, Ryohei Koide; Exogenous PACAP Acts as a Retinoprotective Agent and a Modulator on Microglia/Macrophages Status in Mice NMDA-induced Retinal Injury Model. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6570.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic neuropeptide that belongs to the secretin/glucagon/vasoactive intestinal peptide superfamily. Previously, we have revealed that PACAP has a neuroprotective effect against N-methyl-D-aspartic acid (NMDA)-induced retinal injury. It is recently reported that increment of the number of retinal microglia/macrophage (MG/Mϕ) induced by retinal degenerations contribute to neuroprotection, and one of the microglial activation states, "acquired deactivation" ameliorates neuroinflammation. However, relation between MG/Mϕ and neuroprotective effect of PACAP is still unknown. The aim of this study is to clarify the relationship between the retinoprotective effect of PACAP and the activation of retinal MG/Mϕ on NMDA-induced retinal injury.

Methods: : Adult male C57/BL6 mice were received 40 nM NMDA with/without PACAP injection into their vitreous chamber. At 3 days after the injection, eyes were enucleated and prepared for cryosections for immunohistochemical analysis, and separated retinal samples for real time-PCR analysis. By histological observation, retinal MG/Mϕ labeled by anti-Iba1 antibody and retinal ganglion cells in the retina were counted.

Results: : In NMDA and PACAP co-treated retina, the number of the retinal MG/Mϕ and surviving retinal ganglion cells were significantly higher than that in NMDA-treated retina. The numbers of retinal MG/Mϕ and retinal ganglion cells were significantly correlated. The mRNA levels of several cytokines related to MG/Mϕ activation such as IL-6, IL-10, IFN-γ, TNF-α and TGF-β1 were evaluated by real time PCR method. PACAP co-treatment did not affect pro-inflammatory cytokines such as IL-6, IFN-γ and TNF-α level, but elevated anti-inflammatory cytokines such as TGF-β1 and IL-10 mRNA level significantly in the retina. By double immunostaining, the TGF-β1 immunoreactivity was co-existed with MG/Mϕ marker, CD11b immunoreactivity. The PACAP-induced increment of retinal MG/Mϕ and protection of RGCs attenuate in IL-10 KO mouse.

Conclusions: : These results suggest that PACAP enhances the proliferation or infiltration of retinal MG/Mϕ and modulates activation state to "acquired deactivation" that is known to have a neuroprotective potent in the injured retina.

Keywords: neuroprotection • neuropeptides • microglia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×